Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$1.05−0.04 (-3.67%)
Close on Nov 13, 2026Market cap $12.96MP/E –Yield –
Pluri profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pluri's profit margin for the twelve months ending Sep 30, 2026 was -1943.9%. For fiscal 2026 it was -2344.6%, against -1690.3% the year before. The highest annual figure on record is -816.5% in fiscal 2016.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -2344.6% | −654.2 |
| FY2025 | Jun 30, 2025 | -1690.3% | +4717.0 |
| FY2024 | Jun 30, 2024 | -6407.4% | +3460.6 |
| FY2023 | Jun 30, 2023 | -9867.9% | +7756.8 |
| FY2022 | Jun 30, 2022 | -17624.8% | +109123.0 |
| FY2020 | Jun 30, 2020 | -126747.8% | −61364.5 |
| FY2019 | Jun 30, 2019 | -65383.3% | −13131.3 |
| FY2018 | Jun 30, 2018 | -52252.0% | −51435.5 |
| FY2016 | Jun 30, 2016 | -816.5% | +5694.6 |
| FY2015 | Jun 30, 2015 | -6511.1% | +595.0 |
| FY2014 | Jun 30, 2014 | -7106.1% | −3990.5 |
| FY2013 | Jun 30, 2013 | -3115.6% | −1049.4 |
| FY2012 | Jun 30, 2012 | -2066.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -1368.9% | +482.4 |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -1755.2% | +153.8 |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -3322.2% | −1882.6 |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -3304.5% | −1706.7 |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -1851.3% | −47.0 |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -1909.0% | +4058.7 |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -1439.6% | +6015.4 |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -1597.8% | +3073.6 |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -1804.3% | +7382.7 |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -5967.7% | −148.8 |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -7454.9% | +1308.3 |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -4671.4% | +401178.6 |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -9187.0% | −2151.4 |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -5818.9% | −1603.1 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -8763.2% | +18932.4 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -405850.0% | −388484.0 |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -7035.6% | +212614.4 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -4215.8% | +12242.2 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -27695.7% | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -17366.0% | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -219650.0% | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -16458.0% | – |
See a number that looks wrong?